Iguana Healthcare Management’s Gyre Therapeutics GYRE Stock Holding History

Iguana Healthcare Management’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.58M	Buy	+13,333	New	+$2.49M	1.7%	23

Other funds holding GYRE

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iguana Healthcare Management's GYRE Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Gyre Therapeutics (GYRE) in Q1 2018: 13,333 shares worth $2.58M. The stake represents 1.7% of the portfolio and ranks #23 among its holdings.

56 funds tracked by Wall St. Rank hold GYRE as of Q1 2018.

Iguana Healthcare Management held 13,333 shares of Gyre Therapeutics worth $2.58M as of Q1 2018.
Gyre Therapeutics was a new Iguana Healthcare Management position in Q1 2018.
Gyre Therapeutics made up 1.7% of Iguana Healthcare Management's portfolio in Q1 2018, its #23 holding.
56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.